VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$10.3B
1-Year Est. Return
32.08%
This Fund
S&P 500
1 Year Est. Return
+32.08%
AUM
$10.3B
AUM Growth
+$487M
(+5%)
Holding
2,091
Top Buys
| 1 | +$19.5M | |
| 2 | +$18.2M | |
| 3 | +$14.3M | |
| 4 |
Eli Lilly
LLY
|
+$13.8M |
| 5 |
JPMorgan Chase
JPM
|
+$9.55M |
Top Sells
| 1 | +$5M | |
| 2 | +$4.87M | |
| 3 | +$4.73M | |
| 4 |
DuPont de Nemours
DD
|
+$3.94M |
| 5 |
Procter & Gamble
PG
|
+$2.89M |
Sector Composition
| 1 | Technology | 33.3% |
| 2 | Financials | 14.31% |
| 3 | Consumer Discretionary | 10.17% |
| 4 | Communication Services | 10.06% |
| 5 | Healthcare | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Blend Labs
BLND
$452M
| $41.5K | ﹤0.01% |
13,656
-685
|
|
||
1902
Virgin Galactic
SPCE
$188M
| $41.5K | ﹤0.01% |
12,915
+347
|
|
||
|
ACH
1903
Accendra Health
ACH
$186M
| $41.3K | ﹤0.01% |
14,744
+3,495
|
|
||
1904
Ocugen
OCGN
$606M
| $40.9K | ﹤0.01% |
30,321
+450
|
|
||
1905
Nkarta
NKTX
$183M
| $38.7K | ﹤0.01% |
20,895
-9,443
|
|
||
1906
Vuzix
VUZI
$214M
| $38.1K | ﹤0.01% |
10,078
-914
|
|
||
|
RC
1907
Ready Capital
RC
$315M
| $37.4K | ﹤0.01% |
+17,140
|
|
||
|
CAN
1908
Canaan Creative
CAN
$322M
| $37.2K | ﹤0.01% |
53,902
+23,203
|
|
||
1909
Geron
GERN
$945M
| $35.8K | ﹤0.01% |
27,114
-3,817
|
|
||
|
AUTL
1910
Autolus Therapeutics
AUTL
$436M
| $35.3K | ﹤0.01% |
17,747
-2,413
|
|
||
1911
Iovance Biotherapeutics
IOVA
$1.52B
| $34.5K | ﹤0.01% |
+12,637
|
|
||
1912
The Honest Company
HNST
$319M
| $34.1K | ﹤0.01% |
13,230
+1,736
|
|
||
1913
Xerox
XRX
$222M
| $33.8K | ﹤0.01% |
21,377
-10,087
|
|
||
1914
Lufax Holding
LU
$2.11B
| $33.8K | ﹤0.01% |
13,189
+2,703
|
|
||
1915
Douglas Elliman
DOUG
$203M
| $33.2K | ﹤0.01% |
14,021
+176
|
|
||
1916
Richtech Robotics
RR
$546M
| $33K | ﹤0.01% |
10,207
-496
|
|
||
1917
Evotec
EVO
$1.09B
| $32.9K | ﹤0.01% |
+10,670
|
|
||
1918
Tenaya Therapeutics
TNYA
$121M
| $32.7K | ﹤0.01% |
45,975
+149
|
|
||
1919
Pliant Therapeutics
PLRX
$78M
| $32K | ﹤0.01% |
26,237
-8,506
|
|
||
1920
Braskem
BAK
$1.48B
| $31.1K | ﹤0.01% |
+10,530
|
|
||
1921
C4 Therapeutics
CCCC
$291M
| $29.1K | ﹤0.01% |
15,224
+650
|
|
||
1922
Hyliion Holdings
HYLN
$359M
| $28.4K | ﹤0.01% |
15,439
+1,904
|
|
||
1923
Getty Images
GETY
$324M
| $28.3K | ﹤0.01% |
21,145
-8,359
|
|
||
1924
SciSparc
SPRC
$2.44M
| $27.5K | ﹤0.01% |
+20,224
|
|
||
1925
ImmunityBio
IBRX
$9.96B
| $27.2K | ﹤0.01% |
13,758
+1,057
|
|